Cervical cancer treatment and diagnostics abroad

Cervical cancer starts in the cervix, the lower part of the uterus connecting to the vagina. Most cases are linked to persistent infection with high-risk human papillomavirus, or HPV. A positive HPV test, an abnormal cervical screening result or a precancerous cell change does not by itself mean invasive cancer. These findings need appropriate follow-up, while confirmed invasive disease requires its own specialist assessment and treatment plan.

Investigation may include examination, colposcopy and a biopsy, followed by selected imaging if cancer is found. Treatment depends on the tumour type, size, extent, lymph node findings, general health and personal priorities. Options include surgery, chemoradiation and selected systemic treatments; the same procedure is not appropriate for every stage. Before a consultation, gather screening results, pathology reports and scans. Discuss fertility before treatment begins, along with possible effects on sexual health, bladder or bowel function, and the arrangements for continuing care.

Screening findings are not an invasive cancer diagnosis

Cervical screening aims to detect high-risk HPV and/or abnormal cells before symptoms appear. Some changes need monitoring and others need treatment to reduce the risk of cancer. Precancer is different from invasive disease. The next step depends on the exact result, previous tests and clinical history rather than the word “abnormal” alone.

Unusual bleeding, including after sex or menopause, changes in discharge or persistent pelvic pain should be assessed. Other conditions can cause these symptoms, but a previous normal screening result does not replace an assessment of new symptoms. Do not wait for the next screening invitation if you have a concern.

Confirming cancer and assessing its extent

Colposcopy gives a magnified view of the cervix and may include a biopsy. Tissue examination identifies whether cancer is present and its type. A cone biopsy can provide a larger sample when needed. Ask about preparation, discomfort, possible bleeding and how the result will be explained.

After diagnosis, an oncology team assesses the extent of disease using examination, pathology and selected imaging, such as MRI, CT or PET-CT. The tumour and lymph node findings influence staging and the treatment discussion. Not every patient needs every imaging test.

Treatment according to the clinical setting

Selected early cancers may be treated with surgery; the extent varies with the findings and fertility considerations. Other situations are managed with radiotherapy and chemotherapy together. Brachytherapy delivers radiation internally and is an important part of many cervical cancer radiation plans, rather than a technology automatically replaced by external treatment.

Some disease settings may require immunotherapy, targeted medicines or other systemic treatment. The team considers eligibility, previous therapy and relevant tumour tests. Recurrent or metastatic disease needs an individual plan that also addresses symptoms and quality of life. Neither a stage label nor a treatment name guarantees an outcome.

Fertility, recovery and follow-up

Ask about fertility preservation before starting treatment; suitable options exist only for selected situations. Discuss sexual health, menopause symptoms and possible urinary or bowel effects. Agree who will coordinate follow-up and which symptoms need review between visits. Keep pathology and treatment summaries when care involves several teams.

Frequently asked questions

Does a positive HPV test mean cancer?

No. It indicates infection requiring follow-up according to the result and screening history, not an invasive cancer diagnosis.

Is a cone biopsy enough for every cancer?

No. It may diagnose or treat selected very early disease, but other findings require different treatment.

Can fertility be preserved?

Sometimes, in carefully selected cases. Discuss suitability and specialist advice before treatment begins.

Does HPV vaccination replace screening?

No. Vaccinated people with a cervix should still follow relevant screening recommendations. Vaccination is preventive, not treatment for existing cancer.